Analytica Annual Report to Shareholders 2016

30th September 2016, ASX Announcement

Principal activities of the Group during the yer were:

• The development of strategies on commercial sales of PeriCoach;
• The development of intellectual property of medical device and mobile health application in relation to patents and systems in the pelvic floor exercise field (PeriCoach);
• Development of intellectual property of medical device to assist neurologists and rehabilatise treatment of muscular spasticity. (ELF-2)
• The development of intellectual property in the medical device field in relation to patents in the burette field (AutoStart Infusion System);
• The development of strategies for commerical sales of burette products;

There were no significant changes in the nature of the Group’s principal activities during the year.

To view the full announcement, please click on the button below.